Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Apply
BGB-B2033 & Tislelizumab
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step